Mild cognitive impairment in Parkinson's disease. (Q38090986)

28 August 2017

title

Mild cognitive impairment in Parkinson's disease. (English)

1 reference

mild cognitive impairment

28 August 2017

1 reference

1 reference

inferred from title

cognitive dysfunction

1 reference

1 reference

28 August 2017

publication date

19 March 2013

1 reference

Journal of Neural Transmission

28 August 2017

published in

1 reference

28 August 2017

volume

120

1 reference

28 August 2017

1 reference

28 August 2017

page(s)

517-521

1 reference

The epidemiology of dementia associated with Parkinson's disease

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Heterogeneous neuropathological findings in Parkinson’s disease with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Differences in neuropathologic characteristics across the Lewy body dementia spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Norms for change in episodic memory as a prerequisite for the diagnosis of mild cognitive impairment (MCI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Pathoanatomy of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Cholinergic deficiency and frontal dysfunction in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Rivastigmine for dementia associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

A controlled investigation of current and premorbid personality: characteristics of Parkinson's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

The morbid anatomy of dementia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Mixed dementia--the most common cause of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Comment: should we diagnose MCI in Parkinson disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Parkinson's disease: before the motor symptoms and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Neuroanatomic basis of amnestic MCI differs in patients with and without Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Clinical Lewy body dementia and the impact of vascular components.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Mild cognitive impairment and cognitive reserve in Parkinson’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Subthreshold depression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Cognitive performance in people with Parkinson's disease and mild or moderate depression: effects of dopamine agonists in an add-on to L-dopa therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Depressive symptoms and risk of dementia: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Dopamine deficiency in the cerebral cortex in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Parkinson's and Alzheimer's diseases: epidemiological comparison. 1. Descriptive aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Mild cognitive impairment: conceptual, assessment, ethical, and social issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Parkinson's and Alzheimer's diseases: epidemiological comparison. 2. Persons at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1006-0

Depression and cognitive impairment in patients with mild parkinsonian signs

21 January 2018

1 reference

12 December 2020

Premorbid personality of Parkinson patients

1 reference

12 December 2020

Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?

1 reference

12 December 2020

Risk factors for dementia in Parkinson's disease

1 reference

12 December 2020

Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages).

1 reference

12 December 2020

Vascular parkinsonism

1 reference

12 December 2020

Association of Parkinson's disease with symptoms of attention deficit hyperactivity disorder in childhood.

1 reference

12 December 2020

10.1007/S00702-013-1006-0

Identifiers

DOI

1 reference

28 August 2017

1 reference